IGC Pharma Inc (IGC)
0.3111
+0.01
(+1.67%)
USD |
NYAM |
Jun 08, 16:00
0.3152
0.00 (0.00%)
After-Hours: 20:00
IGC Pharma Price to Book Value: 0.9134 for June 8, 2023
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 07, 2023 | 0.8867 |
| June 06, 2023 | 0.8916 |
| June 05, 2023 | 0.9273 |
| June 02, 2023 | 0.8693 |
| June 01, 2023 | 0.8403 |
| May 31, 2023 | 0.8403 |
| May 30, 2023 | 0.8563 |
| May 26, 2023 | 0.8586 |
| May 25, 2023 | 0.8983 |
| May 24, 2023 | 0.9562 |
| May 23, 2023 | 0.9148 |
| May 22, 2023 | 0.8983 |
| May 19, 2023 | 0.9273 |
| May 18, 2023 | 0.942 |
| May 17, 2023 | 0.9562 |
| May 16, 2023 | 0.9562 |
| May 15, 2023 | 0.9591 |
| May 12, 2023 | 0.9591 |
| May 11, 2023 | 1.020 |
| May 10, 2023 | 1.014 |
| May 09, 2023 | 1.014 |
| May 08, 2023 | 1.016 |
| May 05, 2023 | 1.00 |
| May 04, 2023 | 0.962 |
| May 03, 2023 | 0.962 |
| Date | Value |
|---|---|
| May 02, 2023 | 0.9968 |
| May 01, 2023 | 0.991 |
| April 28, 2023 | 0.9997 |
| April 27, 2023 | 0.9652 |
| April 26, 2023 | 0.9794 |
| April 25, 2023 | 0.9615 |
| April 24, 2023 | 0.971 |
| April 21, 2023 | 1.043 |
| April 20, 2023 | 1.074 |
| April 19, 2023 | 1.026 |
| April 18, 2023 | 0.9852 |
| April 17, 2023 | 0.9638 |
| April 14, 2023 | 0.9302 |
| April 13, 2023 | 0.9626 |
| April 12, 2023 | 0.9562 |
| April 11, 2023 | 0.9849 |
| April 10, 2023 | 0.9849 |
| April 06, 2023 | 0.9852 |
| April 05, 2023 | 0.9635 |
| April 04, 2023 | 0.9716 |
| April 03, 2023 | 1.007 |
| March 31, 2023 | 0.9838 |
| March 30, 2023 | 0.9687 |
| March 29, 2023 | 0.9664 |
| March 28, 2023 | 0.9852 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3032
Minimum
Dec 31 2018
32.25
Maximum
Oct 02 2018
1.990
Average
1.524
Median
Price to Book Value Benchmarks
| Inhibikase Therapeutics Inc | 0.8329 |
| Indaptus Therapeutics Inc | 0.8367 |
| Heart Test Laboratories Inc | -- |
| MAIA Biotechnology Inc | 6.755 |
| CEL-SCI Corp | 5.615 |
Price to Book Value Related Metrics
| PS Ratio | 18.87 |
| PEG Ratio | -0.3030 |
| Price | 0.3111 |
| Earnings Yield | -82.49% |
| Market Cap | 16.51M |
| PEGY Ratio | -0.3030 |